Latest News about PCRX
Recent news which mentions PCRX
What 6 Analyst Ratings Have To Say About Pacira BioSciences
April 20, 2023
Tickers
PCRX
From Benzinga
Earnings Scheduled For February 28, 2023
February 28, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Monday
January 23, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
January 10, 2023
From Benzinga
JetBlue Airways, Pacira BioSciences And Some Other Big Stocks Moving Lower On Tuesday
December 13, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
December 13, 2022
From Benzinga
Best stock picks for 2023: Here are Wall Street analysts’ most heavily favored choices
December 13, 2022
From MarketWatch
These small-cap stocks might make you the most money in 2023, based on two important data points
December 07, 2022
From MarketWatch
Pacira BioSciences's Return On Capital Employed Insights
November 23, 2022
Tickers
PCRX
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
November 16, 2022
From Benzinga
Pacira Touts Positive Data From EXPAREL Study In Toe Correction Surgery
September 21, 2022
Tickers
PCRX
From Benzinga
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
September 07, 2022
From Benzinga
Pacira Posts Topline Data From Knee Surgery Study With Its Flagship Pain Management Drug
September 07, 2022
Tickers
PCRX
From Benzinga
10 Biggest Price Target Changes For Wednesday
June 15, 2022
From Benzinga
Pacira BioSciences Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 28, 2022
Tickers
PCRX
From Benzinga
3 Small-Cap Medical Stocks With Big Momentum
April 27, 2022
From Motley Fool
28 Biggest Movers From Yesterday
April 12, 2022
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
April 07, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.